<DOC>
	<DOCNO>NCT01721421</DOCNO>
	<brief_summary>Design : Prospective randomise cross-over study . Fifty-two eligible patient randomise treatment time either 6 hour 4 hour period 24 week follow washout period 4 week , switch alternative treatment time additional 24 week . Aims : To examine feasibility effect extend dialysis treatment time , 6 hour thrice weekly , versus standard , 4 hour thrice weekly , compare difference baseline outcome measure total 12-month period . Primary outcome measure 1 ] Serum albumin Secondary outcome measure Nutritional status 1 . Malnutrition-inflammation score 2 . Dietary intake 3 . Hand-Grip strength 4 . Energy expenditure Quality life 1 . Patient report quality life 2. time recovery dialysis Serum biomarkers 1 . BNP 2 . Troponin 3 . MCP-1 Others 24- hour Ambulatory blood pressure 24-hour accelerometer Population : Local haemodialysis population 1200 patient Eligibility : Minimum 90days haemodialysis treatment Duration : Fifty-six week</brief_summary>
	<brief_title>Effects Extended Haemodialysis Treatment Duration Patients With End-stage Renal Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Dialysis dependant 90 day 1 . Haemodialysis le 90 day 2 . Patients anticipated life expectancy le 6 month secondary significant morbidity e.g . metastatic malignancy , advance human immunodeficiency virus 3 . Patients acute liver disease ; History underlie haematological condition ; 4 . Elective planned change renal replacement modality within 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>haemodialysis</keyword>
	<keyword>Crossover</keyword>
	<keyword>Treatment time</keyword>
	<keyword>nutritional status</keyword>
</DOC>